data_1oav_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1oav _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.29 0.567 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.418 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 11.5 mttt -88.59 -171.82 3.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.483 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 2' ' ' LYS . 0.7 OUTLIER 71.07 64.21 0.17 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 109.451 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.47 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 5.3 p -164.32 -174.54 3.55 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.28 -0.887 . . . . 0.0 109.749 -179.819 47.077 70.872 100.376 103.438 2.015 104.543 -38.702 -69.495 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.447 HD13 ' HB2' ' A' ' 12' ' ' CYS . 56.3 mt -119.77 103.9 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.017 -1.052 . . . . 0.0 110.123 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.553 ' CA ' ' HB2' ' A' ' 20' ' ' CYS . . . -79.97 6.75 10.48 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.227 -0.921 . . . . 0.0 110.234 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 8' ' ' ASP . 6.9 mtpp -83.65 110.36 18.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.188 -0.945 . . . . 0.0 109.895 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 7' ' ' LYS . 6.9 m-20 -43.87 139.22 2.43 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.474 ' CZ ' ' HD3' ' A' ' 37' ' ' LYS . 3.0 m-85 56.53 44.79 23.54 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 11' ' ' ARG . . . -89.71 110.86 3.79 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -178.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.467 ' HG2' ' HG2' ' A' ' 35' ' ' GLU . 2.7 mtm-85 -43.3 120.21 1.82 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.341 -1.093 . . . . 0.0 109.423 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.489 ' SG ' ' N ' ' A' ' 13' ' ' LYS . 0.0 OUTLIER -143.13 172.72 12.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 108.874 -179.931 122.416 -69.154 -144.753 104.372 2.021 103.847 131.691 -142.911 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.489 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -131.49 151.6 51.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.132 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.608 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 12.7 m0 -66.9 -11.71 57.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.344 -0.848 . . . . 0.0 109.709 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.51 7.3 10.46 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.483 ' HA3' ' HG3' ' A' ' 13' ' ' LYS . . . -120.87 -120.92 2.79 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -90.34 129.92 43.62 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.231 -1.158 . . . . 0.0 110.26 -179.38 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.73 -151.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.754 2.303 . . . . 0.0 109.713 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.538 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -117.79 149.06 41.43 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.963 -22.427 -75.617 -67.861 105.109 2.024 104.876 -99.251 -87.385 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.553 ' HB2' ' CA ' ' A' ' 6' ' ' ALA . 99.7 m -87.56 -75.1 0.42 Allowed 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 122.279 1.038 . . . . 0.0 109.284 -179.155 -69.495 -38.702 100.376 104.543 2.015 103.438 70.872 47.077 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -35.51 -29.49 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.079 -178.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 120.78 31.36 1.23 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.563 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 2.3 mmt-85 -80.32 163.75 23.68 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.683 -0.892 . . . . 0.0 109.825 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.06 118.75 4.98 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.57 87.25 0.12 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.586 -0.949 . . . . 0.0 109.79 -179.421 -142.911 131.691 -144.753 103.847 2.021 104.372 -69.154 122.416 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.18 134.78 30.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -107.15 -168.86 1.45 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.287 -0.883 . . . . 0.0 109.456 179.954 -136.91 110.636 -107.118 104.048 2.022 105.453 7.92 -74.361 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.499 ' O ' HG21 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -88.12 30.93 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.332 -0.855 . . . . 0.0 109.765 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.499 HG21 ' O ' ' A' ' 28' ' ' SER . 1.0 OUTLIER 52.19 19.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.52 -0.738 . . . . 0.0 110.008 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -129.68 -14.15 4.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 109.907 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.68 17.42 17.06 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -144.33 159.22 43.07 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.273 -1.133 . . . . 0.0 109.583 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 32' ' ' THR . 5.4 m-80 65.95 42.04 3.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 110.062 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 58.7 m -75.46 141.14 43.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.134 -0.979 . . . . 0.0 109.109 179.6 -74.361 7.92 -107.118 105.453 2.022 104.048 110.636 -136.91 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 34' ' ' CYS . 20.9 mt-10 -155.56 152.57 28.96 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.077 -1.014 . . . . 0.0 110.359 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.494 ' HB3' ' HB2' ' A' ' 23' ' ' ARG . 3.7 m -92.5 106.15 18.19 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.466 -87.385 -99.251 -67.861 104.876 2.024 105.109 -75.617 -22.427 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.563 ' O ' ' HB3' ' A' ' 23' ' ' ARG . 3.4 mtmt -96.95 155.88 37.04 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.444 -0.785 . . . . 0.0 109.392 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.512 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . 30.5 Cg_endo -70.16 80.12 1.02 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.271 1.981 . . . . 0.0 111.435 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.486 ' C ' ' O ' ' A' ' 38' ' ' PRO . 1.9 ttt180 28.84 98.9 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.179 0.514 . . . . 0.0 111.235 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.2 mt -127.92 122.92 33.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.199 -0.938 . . . . 0.0 109.335 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.456 ' O ' ' CG2' ' A' ' 41' ' ' ILE . 2.2 mp -147.57 76.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.227 -0.92 . . . . 0.0 109.771 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.3 ttt -110.78 102.9 11.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.104 -0.998 . . . . 0.0 109.349 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -91.87 -163.86 1.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 109.394 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.46 -39.67 0.36 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.74 -30.32 31.94 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.275 -1.133 . . . . 0.0 109.743 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -96.1 -27.47 10.13 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -63.41 1.08 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -1.152 . . . . 0.0 109.552 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.429 -179.932 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.29 0.567 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.418 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 11.5 mttt -88.59 -171.82 3.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.483 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 2' ' ' LYS . 0.7 OUTLIER 71.07 64.21 0.17 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 109.451 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.484 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 5.3 p -164.32 -174.54 3.55 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.28 -0.887 . . . . 0.0 109.749 -179.819 47.077 70.872 100.376 103.438 2.015 104.543 -38.702 -69.495 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.564 HD12 ' HB2' ' A' ' 12' ' ' CYS . 56.3 mt -119.77 103.9 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.017 -1.052 . . . . 0.0 110.123 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.563 ' CA ' ' HB2' ' A' ' 20' ' ' CYS . . . -79.97 6.75 10.48 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.227 -0.921 . . . . 0.0 110.234 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 8' ' ' ASP . 6.9 mtpp -83.65 110.36 18.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.188 -0.945 . . . . 0.0 109.895 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 7' ' ' LYS . 6.9 m-20 -43.87 139.22 2.43 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.494 ' OH ' ' HD3' ' A' ' 37' ' ' LYS . 3.0 m-85 56.53 44.79 23.54 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 11' ' ' ARG . . . -89.71 110.86 3.79 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -178.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.474 ' HG2' ' HG2' ' A' ' 35' ' ' GLU . 2.7 mtm-85 -43.3 120.21 1.82 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.341 -1.093 . . . . 0.0 109.423 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.564 ' HB2' HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -143.13 172.72 12.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 108.874 -179.931 122.416 -69.154 -144.753 104.372 2.021 103.847 131.691 -142.911 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.489 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -131.49 151.6 51.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.132 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.608 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 12.7 m0 -66.9 -11.71 57.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.344 -0.848 . . . . 0.0 109.709 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.51 7.3 10.46 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.475 ' HA3' ' HG3' ' A' ' 13' ' ' LYS . . . -120.87 -120.92 2.79 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -90.34 129.92 43.62 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.231 -1.158 . . . . 0.0 110.26 -179.38 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.73 -151.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.754 2.303 . . . . 0.0 109.713 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.522 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -117.79 149.06 41.43 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.963 -22.427 -75.617 -67.861 105.109 2.024 104.876 -99.251 -87.385 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.563 ' HB2' ' CA ' ' A' ' 6' ' ' ALA . 99.7 m -87.56 -75.1 0.42 Allowed 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 122.279 1.038 . . . . 0.0 109.284 -179.155 -69.495 -38.702 100.376 104.543 2.015 103.438 70.872 47.077 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -35.51 -29.49 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.079 -178.606 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 120.78 31.36 1.23 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.568 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 2.3 mmt-85 -80.32 163.75 23.68 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.683 -0.892 . . . . 0.0 109.825 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.06 118.75 4.98 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.57 87.25 0.12 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.586 -0.949 . . . . 0.0 109.79 -179.421 -142.911 131.691 -144.753 103.847 2.021 104.372 -69.154 122.416 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.18 134.78 30.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -107.15 -168.86 1.45 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.287 -0.883 . . . . 0.0 109.456 179.954 -136.91 110.636 -107.118 104.048 2.022 105.453 7.92 -74.361 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.565 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -88.12 30.93 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.332 -0.855 . . . . 0.0 109.765 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 29' ' ' ILE . 1.0 OUTLIER 52.19 19.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.52 -0.738 . . . . 0.0 110.008 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -129.68 -14.15 4.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 109.907 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.68 17.42 17.06 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -144.33 159.22 43.07 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.273 -1.133 . . . . 0.0 109.583 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 32' ' ' THR . 5.4 m-80 65.95 42.04 3.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 110.062 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 58.7 m -75.46 141.14 43.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.134 -0.979 . . . . 0.0 109.109 179.6 -74.361 7.92 -107.118 105.453 2.022 104.048 110.636 -136.91 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 34' ' ' CYS . 20.9 mt-10 -155.56 152.57 28.96 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.077 -1.014 . . . . 0.0 110.359 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.521 ' HB3' ' HB2' ' A' ' 23' ' ' ARG . 3.7 m -92.5 106.15 18.19 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.466 -87.385 -99.251 -67.861 104.876 2.024 105.109 -75.617 -22.427 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.568 ' O ' ' HB3' ' A' ' 23' ' ' ARG . 3.4 mtmt -96.95 155.88 37.04 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.444 -0.785 . . . . 0.0 109.392 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.521 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . 30.5 Cg_endo -70.16 80.12 1.02 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.271 1.981 . . . . 0.0 111.435 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.486 ' C ' ' O ' ' A' ' 38' ' ' PRO . 1.9 ttt180 28.84 98.9 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.179 0.514 . . . . 0.0 111.235 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.501 ' HA ' HD23 ' A' ' 40' ' ' LEU . 4.2 mt -127.92 122.92 33.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.199 -0.938 . . . . 0.0 109.335 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.684 ' O ' HG22 ' A' ' 41' ' ' ILE . 2.2 mp -147.57 76.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.227 -0.92 . . . . 0.0 109.771 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.3 ttt -110.78 102.9 11.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.104 -0.998 . . . . 0.0 109.349 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -91.87 -163.86 1.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 109.394 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.46 -39.67 0.36 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.564 HD23 ' H ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -52.74 -30.32 31.94 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.275 -1.133 . . . . 0.0 109.743 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -96.1 -27.47 10.13 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -63.41 1.08 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -1.152 . . . . 0.0 109.552 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.429 -179.932 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.29 0.567 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.418 ' O ' ' CB ' ' A' ' 3' ' ' LYS . 11.5 mttt -88.59 -171.82 3.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.257 -0.902 . . . . 0.0 109.483 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 2' ' ' LYS . 0.7 OUTLIER 71.07 64.21 0.17 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.223 -0.923 . . . . 0.0 109.451 -179.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.484 ' HB2' ' C ' ' A' ' 19' ' ' CYS . 5.3 p -164.32 -174.54 3.55 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.28 -0.887 . . . . 0.0 109.749 -179.819 47.077 70.872 100.376 103.438 2.015 104.543 -38.702 -69.495 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.564 HD12 ' HB2' ' A' ' 12' ' ' CYS . 56.3 mt -119.77 103.9 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.017 -1.052 . . . . 0.0 110.123 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.563 ' CA ' ' HB2' ' A' ' 20' ' ' CYS . . . -79.97 6.75 10.48 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.227 -0.921 . . . . 0.0 110.234 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 8' ' ' ASP . 6.9 mtpp -83.65 110.36 18.21 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.188 -0.945 . . . . 0.0 109.895 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 7' ' ' LYS . 6.9 m-20 -43.87 139.22 2.43 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.494 ' OH ' ' HD3' ' A' ' 37' ' ' LYS . 3.0 m-85 56.53 44.79 23.54 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 11' ' ' ARG . . . -89.71 110.86 3.79 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -178.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.474 ' HG2' ' HG2' ' A' ' 35' ' ' GLU . 2.7 mtm-85 -43.3 120.21 1.82 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.341 -1.093 . . . . 0.0 109.423 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.564 ' HB2' HD12 ' A' ' 5' ' ' ILE . 0.0 OUTLIER -143.13 172.72 12.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 108.874 -179.931 122.416 -69.154 -144.753 104.372 2.021 103.847 131.691 -142.911 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.489 ' N ' ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -131.49 151.6 51.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.132 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.608 ' N ' ' CD1' ' A' ' 14' ' ' TRP . 12.7 m0 -66.9 -11.71 57.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.344 -0.848 . . . . 0.0 109.709 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.51 7.3 10.46 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.475 ' HA3' ' HG3' ' A' ' 13' ' ' LYS . . . -120.87 -120.92 2.79 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -90.34 129.92 43.62 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.231 -1.158 . . . . 0.0 110.26 -179.38 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -80.73 -151.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.754 2.303 . . . . 0.0 109.713 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.522 ' CB ' ' HB2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -117.79 149.06 41.43 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.963 -22.427 -75.617 -67.861 105.109 2.024 104.876 -99.251 -87.385 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.563 ' HB2' ' CA ' ' A' ' 6' ' ' ALA . 99.7 m -87.56 -75.1 0.42 Allowed 'General case' 0 C--N 1.289 -2.024 0 CA-C-O 122.279 1.038 . . . . 0.0 109.284 -179.155 -69.495 -38.702 100.376 104.543 2.015 103.438 70.872 47.077 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -35.51 -29.49 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.079 -178.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 20' ' ' CYS . . . 120.78 31.36 1.23 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.568 ' HB3' ' O ' ' A' ' 37' ' ' LYS . 2.3 mmt-85 -80.32 163.75 23.68 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.683 -0.892 . . . . 0.0 109.825 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.06 118.75 4.98 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.57 87.25 0.12 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.586 -0.949 . . . . 0.0 109.79 -179.421 -142.911 131.691 -144.753 103.847 2.021 104.372 -69.154 122.416 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.18 134.78 30.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 34' ' ' CYS . 0.2 OUTLIER -107.15 -168.86 1.45 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.287 -0.883 . . . . 0.0 109.456 179.954 -136.91 110.636 -107.118 104.048 2.022 105.453 7.92 -74.361 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.565 ' O ' HG22 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -88.12 30.93 0.82 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.332 -0.855 . . . . 0.0 109.765 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.65 HG23 ' O ' ' A' ' 29' ' ' ILE . 1.0 OUTLIER 52.19 19.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.52 -0.738 . . . . 0.0 110.008 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -129.68 -14.15 4.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -0.879 . . . . 0.0 109.907 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.68 17.42 17.06 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.471 ' O ' ' HB2' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -144.33 159.22 43.07 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.273 -1.133 . . . . 0.0 109.583 -179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 32' ' ' THR . 5.4 m-80 65.95 42.04 3.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 110.062 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 58.7 m -75.46 141.14 43.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.134 -0.979 . . . . 0.0 109.109 179.6 -74.361 7.92 -107.118 105.453 2.022 104.048 110.636 -136.91 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 34' ' ' CYS . 20.9 mt-10 -155.56 152.57 28.96 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.077 -1.014 . . . . 0.0 110.359 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.521 ' HB3' ' HB2' ' A' ' 23' ' ' ARG . 3.7 m -92.5 106.15 18.19 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.466 -87.385 -99.251 -67.861 104.876 2.024 105.109 -75.617 -22.427 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.568 ' O ' ' HB3' ' A' ' 23' ' ' ARG . 3.4 mtmt -96.95 155.88 37.04 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.444 -0.785 . . . . 0.0 109.392 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.521 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . 30.5 Cg_endo -70.16 80.12 1.02 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.271 1.981 . . . . 0.0 111.435 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.486 ' C ' ' O ' ' A' ' 38' ' ' PRO . 1.9 ttt180 28.84 98.9 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.179 0.514 . . . . 0.0 111.235 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.501 ' HA ' HD23 ' A' ' 40' ' ' LEU . 4.2 mt -127.92 122.92 33.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.199 -0.938 . . . . 0.0 109.335 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.684 ' O ' HG22 ' A' ' 41' ' ' ILE . 2.2 mp -147.57 76.6 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 121.227 -0.92 . . . . 0.0 109.771 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 6.3 ttt -110.78 102.9 11.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.104 -0.998 . . . . 0.0 109.349 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -91.87 -163.86 1.1 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 109.394 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 162.46 -39.67 0.36 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.564 HD23 ' H ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -52.74 -30.32 31.94 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.275 -1.133 . . . . 0.0 109.743 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -96.1 -27.47 10.13 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -63.41 1.08 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -1.152 . . . . 0.0 109.552 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.429 -179.932 . . . . . . . . 0 0 . 1 stop_ save_